✦ LIBER ✦
4.P.55 Troglitazone, a novel antidiabetic agent, reduces oxidation of low density lipoprotein and E-selectin plasma concentration in NIDDM patients
✍ Scribed by Cominacini, L.; Foot, E.; Garbin, U.; Fratta Pasini, A.; Campagnola, M.; Davoli, A.; Rigoni, A.; Ferrannini, E.
- Book ID
- 123422922
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 148 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0021-9150
No coin nor oath required. For personal study only.